Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

133.40
Delayed Data
As of Aug 18
 -1.23 / -0.91%
Today’s Change
96.18
Today|||52-Week Range
145.42
+9.03%
Year-to-Date
Horizon Pharma (HZNP) Soars: Stock Adds 10.5% in Session
Aug 18 / Zacks.com - Paid Partner Content
Daniel Loeb Buys 8 Stocks in 2nd Quarter
Aug 16 / GuruFocus News - Paid Partner Content
Seattle Genetics' Adcetris Granted Priority Review by FDA
Aug 17 / Zacks.com - Paid Partner Content
MiMedx Group (MDXG) in Focus: Stock Moves 6.1% Higher
Aug 16 / Zacks.com - Paid Partner Content
Novo Nordisk's Semaglutide Shows Remarkable Results in Study
Aug 17 / Zacks.com - Paid Partner Content
Ardsley Advisory Partners Buys Alexion Pharmaceuticals Inc, Silver Spring Networks In...
Aug 14 / GuruFocus News - Paid Partner Content
Spectrum (SPPI) Initiates Phase II Study for Cancer Drug
Aug 16 / Zacks.com - Paid Partner Content
Regeneron vs. Alexion: Which Stock is a Better Pick Post Q2 Earnings?
Aug 14 / Zacks.com - Paid Partner Content
Shire Files Marketing Application for Lifitegrast in Europe
Aug 16 / Zacks.com - Paid Partner Content
Editas Medicine (EDIT) Looks Good: Stock Moves Up 11.3%
Aug 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close134.63
Today’s open134.28
Day’s range132.99 - 134.92
Volume1,416,434
Average volume (3 months)2,688,242
Market cap$29.8B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)+162.69%
Earnings growth (this year)+21.20%
Earnings growth (next 5 years)+18.90%
Revenue growth (last year)+21.11%
P/E ratio57.7
Price/Sales9.22
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc-0.15-0.25%
BAXBaxter International...+0.05+0.08%
INCYIncyte Corp-0.55-0.45%
VRTXVertex Pharmaceutica...-0.41-0.28%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateOctober 26, 2017
EPS forecast (this quarter)$1.33
Annual revenue (last year)$3.0B
Annual profit (last year)$399.0M
Net profit margin13.25%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ludwig N. Hantson
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts